The medical risks of obesity
On July 23rd, a federal advisory committee votes on whether to recommend that compounding pharmacies be allowed to make seven peptides, BPC-157, TB-500, and MOTS-c among them, that the FDA has never approved and that carry almost no human trial data
When tirzepatide stops working or never worked well to begin with, exploring alternatives becomes necessary rather than optional
This will look different for everyone, but should include eating more protein and nutrient-dense foods including fruits and vegetables
With consistent support, he focused on large, satisfying meals built around protein and volume , rather than restriction